- Company
- Rexahn Pharmaceuticals, Inc.
- Ticker
- REXN
Levi & Korsinsky announces it has commenced an investigation of Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) concerning possible breaches of fiduciary duty.
To receive more information, please fill out the form.